The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis

The impact of bevacizumab (an anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of epithelial ovarian cancer (EOC). To investigate the efficacy of bevacizumab combinations with different regimens in the treatment of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guanyu, Ye, Lixiang, Liu, Guifen, An, Jian, Sehouli, Jalid, Sun, Pengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788992/
https://www.ncbi.nlm.nih.gov/pubmed/29416352
http://dx.doi.org/10.2147/OTT.S155581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788992/
https://www.ncbi.nlm.nih.gov/pubmed/29416352
http://dx.doi.org/10.2147/OTT.S155581

Ejemplares similares